LIPC and Insulin resistance: Insulin resistance adversely affects enzymes such as LPL and hepatic lipase (HL), leading to conditions that are highly atherogenic, such as a decrease in HDL and increases in small-dense LDL (SdLDL) and remnant lipoproteins [47].